Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367920-16-000052
Filing Date
2016-11-08
Accepted
2016-11-08 07:35:46
Documents
53
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q q3201610-q.htm 10-Q 1029535
2 EXHIBIT 31.1 q32016exhibit311.htm EX-31.1 12539
3 EXHIBIT 31.2 q32016exhibit312.htm EX-31.2 12599
4 EXHIBIT 32.1 q32016exhibit321.htm EX-32.1 6830
5 EXHIBIT 32.2 q32016exhibit322.htm EX-32.2 6746
12 pipelinea01.jpg GRAPHIC 101452
  Complete submission text file 0001367920-16-000052.txt   4669574

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cnce-20160930.xml EX-101.INS 905768
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnce-20160930.xsd EX-101.SCH 30641
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cnce-20160930_cal.xml EX-101.CAL 59532
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnce-20160930_def.xml EX-101.DEF 141175
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnce-20160930_lab.xml EX-101.LAB 430682
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnce-20160930_pre.xml EX-101.PRE 263243
Mailing Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36310 | Film No.: 161979971
SIC: 2834 Pharmaceutical Preparations